Method for producing dispersible sterol and stanol compounds
    2.
    发明授权
    Method for producing dispersible sterol and stanol compounds 有权
    分散性甾醇和甾烷醇化合物的制备方法

    公开(公告)号:US06387411B2

    公开(公告)日:2002-05-14

    申请号:US09826072

    申请日:2001-04-04

    IPC分类号: A61K914

    摘要: A method for preparing sterol/stanol and sterol/stanol ester compositions with improved dispersibility is provided by co-melting the sterol/stanol and/or sterol/stanol ester with highly branched hydrocarbons and then grinding the resulting product. A method for preparing the compounds is also disclosed. The ground compound is suitable for formulating into orally administered products suitable for control of blood serum cholesterol.

    摘要翻译: 通过将甾醇/甾烷醇和/或甾醇/甾烷醇酯与高度支化的烃共熔,然后研磨所得产物,提供了具有改进的分散性的固醇/甾烷醇和甾醇/甾烷醇酯组合物的制备方法。 还公开了一种制备该化合物的方法。 地面化合物适用于配制成适合于控制血清胆固醇的口服制剂。

    Method for producing dispersible sterol and stanol compounds
    3.
    发明授权
    Method for producing dispersible sterol and stanol compounds 有权
    分散性甾醇和甾烷醇化合物的制备方法

    公开(公告)号:US06242001B1

    公开(公告)日:2001-06-05

    申请号:US09200623

    申请日:1998-11-30

    IPC分类号: A61K914

    摘要: A method for preparing sterol/stanol and sterol/stanol ester compositions with improved dispersibility is provided by co-melting the sterol/stanol and/or sterol/stanol ester with highly branched hydrocarbons and then grinding the resulting product. A method for preparing the compounds is also disclosed. The ground compound is suitable for formulating into orally administered products suitable for control of blood serum cholesterol.

    摘要翻译: 通过将甾醇/甾烷醇和/或甾醇/甾烷醇酯与高度支化的烃共熔,然后研磨所得产物,提供了具有改进的分散性的固醇/甾烷醇和甾醇/甾烷醇酯组合物的制备方法。 还公开了一种制备该化合物的方法。 地面化合物适用于配制成适合于控制血清胆固醇的口服制剂。

    Simethicone containing pharmaceutical compositions
    6.
    发明授权
    Simethicone containing pharmaceutical compositions 失效
    含二甲聚硅氧烷的药物组合物

    公开(公告)号:US5716641A

    公开(公告)日:1998-02-10

    申请号:US619116

    申请日:1996-03-20

    摘要: A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a pharmaceutical suitable for the treatment of gastric disorders selected from the group consisting of cimetidine, ranitidine, famotidine, diphenoxylate, loperamide, loperamide-N-oxide, pharmaceutically acceptable salts thereof and combinations thereof; and a therapeutically effective amount of simethicone wherein the pharmaceutical and simethicone are separated by a barrier which is substantially impermeable to simethicone.

    摘要翻译: 一种用于治疗胃肠道疾病的固体口服剂型,其包含治疗有效量的适用于治疗选自西咪替丁,雷尼替丁,法莫替丁,二苯甲酸盐,洛哌丁胺,洛哌丁胺-N-氧化物,药学上可接受的组合物 其盐及其组合; 和治疗有效量的二甲硅油,其中药物和二甲硅油通过对于二甲硅油基本上不可渗透的屏障分离。

    Simethicone containing pharmaceutical compositions
    7.
    发明授权
    Simethicone containing pharmaceutical compositions 失效
    含二甲聚硅氧烷的药物组合物

    公开(公告)号:US5679376A

    公开(公告)日:1997-10-21

    申请号:US455443

    申请日:1995-05-31

    摘要: A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a pharmaceutical suitable for the treatment of gastric disorders selected from the group consisting of cimetidine, ranitidine, famotidine, diphenoxylate, loperamide, loperamide-N-oxide, pharmaceutically acceptable salts thereof and combinations thereof; and a therapeutically effective amount of simethicone wherein the pharmaceutical and simethicone are separated by a barrier which is substantially impermeable to simethicone.

    摘要翻译: 一种用于治疗胃肠道疾病的固体口服剂型,其包含治疗有效量的适用于治疗选自西咪替丁,雷尼替丁,法莫替丁,二苯甲酸盐,洛哌丁胺,洛哌丁胺-N-氧化物,药学上可接受的组合物 其盐及其组合; 和治疗有效量的二甲硅油,其中药物和二甲硅油通过对于二甲硅油基本上不可渗透的屏障分离。

    Multiphase soft gelatin dosage form
    9.
    发明授权
    Multiphase soft gelatin dosage form 失效
    多相软明胶剂型

    公开(公告)号:US6024980A

    公开(公告)日:2000-02-15

    申请号:US671979

    申请日:1996-06-28

    申请人: Michael R. Hoy

    发明人: Michael R. Hoy

    CPC分类号: A61K9/4808

    摘要: The present invention relates to a dosage form containing a common enclosure of polymeric material. The enclosure contains multiple phases of semi-solid fill materials containing active ingredients.

    摘要翻译: 本发明涉及含有聚合物材料的共同外壳的剂型。 外壳包含多个含有活性成分的半固体填充材料。